How Biotech Startups Are Using Organ Chips to Replace Animal Testing

Episode 17 of Biotech Business with Fexingo explores the rise of organ-on-a-chip technology in preclinical drug development. Lucas and Luna examine how startups like Emulate and CN Bio are building microfluidic devices that mimic human organ function — from liver to lung to gut — and how these chips are starting to replace traditional animal models. They discuss the science behind the chips, the regulatory push from the FDA's Modernization Act 2.0, and why venture capital is pouring into this space. Specific focus on Emulate's colon chip used to study inflammatory bowel disease and a recent $100 million Series C round. The hosts also touch on the cost savings for small biotechs, the limitations of current chip models, and what the next five years could look like for a world with fewer lab animals and more human-relevant data. #OrganOnAChip #Emulate #CNBio #DrugDevelopment #AnimalTestingAlternatives #FDAmodernization #BiotechStartups #PreclinicalResearch #Microfluidics #InflammatoryBowelDisease #VentureCapital #SeriesC #LifeSciences #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #LabOnAChip #HumanRelevantData Keep every episode free: buymeacoffee.com/fexingo